General Information of the Compound
| Compound ID |
CP0022970
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-Morpholin-4-yl-pyrimido[2,1-a]isoquinolin-4-one
Show/Hide
|
||||||||||||||||||
| Synonyms |
168425-64-7
2-(4-MORPHOLINYL)-4H-PYRIMIDO[2,1-A]ISOQUINOLIN-4-ONE
2-(morpholin-4-yl)pyrimido[2,1-a]isoquinolin-4-one
2-Morpholin-4-yl-pyrimido[2,1-a]isoquinolin-4-one
2-morpholino-4H-pyrimido[2,1-a]isoquinolin-4-one
AKOS016369524
B7337
BCP04303
BDBM50159620
CHEMBL179242
CS-5624
CTK4D2994
Compound 401
Compound401
DTXSID20434626
EX-A1016
HMS3229D15
HY-19341
J-010456
KB-224235
KS-00001DEG
M2537
MolPort-023-276-726
NCGC00378805-02
S-7713
SCHEMBL10092321
ZINC13608047
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H15N3O2
|
||||||||||||||||||
| Molecular Weight |
281.315
|
||||||||||||||||||
| Canonical SMILES |
O=c1cc(nc2c3ccccc3ccn12)N1CCOCC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H15N3O2/c20-15-11-14(18-7-9-21-10-8-18)17-16-13-4-2-1-3-12(13)5-6-19(15)16/h1-6,11H,7-10H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
BVRDQVRQVGRNHG-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound